InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by venBio Global Strategic Fund III, L.P.. Officer active across 4 companies, notably Elevation Oncology, Inc.. In total, 7 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €2.7m. History available since 25 May 2022. The latest transaction was filed on 25 May 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations7 total
843,592 sharesCommon StockSEC:0000905148-24-001964:0
3,786,957 sharesCommon StockSEC:0000905148-23-000957:0
702,737 shares@ US$4.1236100.0% of flowCommon StockSEC:0001140361-22-021085:0
3,684,769 sharesCommon StockSEC:0001567619-21-018677:0
3,684,769 sharesCommon StockSEC:0001567619-21-018677
1,983,167 sharesCommon StockSEC:0001567619-21-012858:0
1,983,167 sharesCommon StockSEC:0001567619-21-012858
7 of 7 declarations
About venBio Global Strategic Fund III, L.P.
venBio Global Strategic Fund III, L.P. is a director and insider at Elevation Oncology, Inc. and Ventyx Biosciences, Inc.
